Sharon Shacham

Director/Board Member presso ACRIVON THERAPEUTICS, INC.

Patrimonio netto: 55 985 $ in data 31/03/2024

53 anni

Health Technology

Consumer Services

Profilo

Sharon Shacham is the founder of Karyopharm Therapeutics, Inc., which was founded in 2008.
She is currently an Independent Director at Acrivon Therapeutics, Inc. since 2020.
Dr. Shacham has previously worked as a Director of Algorithm & Software Development at Predix Pharmaceuticals, Inc. and as a Senior Vice President of Drug Development at EPIX Pharmaceuticals, Inc. from 2000 to 2009.
She has an educational background from Tel-Aviv University, where she obtained undergraduate, MBA, and doctorate degrees.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
ACRIVON THERAPEUTICS, INC. 0.03%	24/04/2023	7 830 ( 0.03% )	55 985 $	31/03/2024

Posizioni attive di Sharon Shacham

Società	Posizione	Inizio
ACRIVON THERAPEUTICS, INC.	Director/Board Member	01/10/2020

Tutte le posizioni attive di Sharon Shacham

Precedenti posizioni note di Sharon Shacham

Società	Posizione	Fine
KARYOPHARM THERAPEUTICS INC.	Founder	03/05/2021
EPIX Pharmaceuticals, Inc. EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA.	Corporate Officer/Principal	01/04/2009
Predix Pharmaceuticals, Inc. Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Predix Pharmaceuticals, Inc. develops novel drugs and other related products. It is a clinical stage drug development company that uses proprietary discovery and lead optimization engine to develop novel drugs for G-protein coupled receptor (GPCR) and ion channel targets. The company was founded by Silvia Noiman, Haim Aviv, Oren M. Becker and Oren M. Ramot in September, 2002 and is headquartered in Woburn, MA.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Sharon Shacham

Formazione di Sharon Shacham

Tel-Aviv University

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Sharon Shacham

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
KARYOPHARM THERAPEUTICS INC.	Health Technology
ACRIVON THERAPEUTICS, INC.	Health Technology

Aziende private	2
EPIX Pharmaceuticals, Inc. EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA.	Health Technology
Predix Pharmaceuticals, Inc. Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Predix Pharmaceuticals, Inc. develops novel drugs and other related products. It is a clinical stage drug development company that uses proprietary discovery and lead optimization engine to develop novel drugs for G-protein coupled receptor (GPCR) and ion channel targets. The company was founded by Silvia Noiman, Haim Aviv, Oren M. Becker and Oren M. Ramot in September, 2002 and is headquartered in Woburn, MA.	Health Technology